A study in collaboration with researchers at the University of New South Wales for co-designing tools for increasing epilepsy clinical trial awareness.
Inclusion Criteria:
A pilot study to investigate the effect of Cannabidiol* on quality of life and beyond-seizure outcomes in children and adults with DEE.
* This will be a TGA-approved Cannabidiol medicine for epilepsy
Inclusion Criteria
Exclusion Criteria
Mixed methods study to co-design clinical trials with epilepsy patients, epilepsy advocacy groups, clinicians and researchers.
Inclusion
An open-label study to profile how advanced cancer patients use a range of cannabis medicines for symptom relief to assess dose, efficacy, safety, pharmacokinetics and pharmacodynamics.
Inclusion
Participants can continue to receive standard concomitant care and interventions, such as chemotherapy and radiotherapy, and take medications for other conditions as usual in the advanced care population